Evidence Synthesis
Medicap Q's gross margin accelerated to 44.72%, up from -81.97%.
The company's marginal operating leverage decelerated, while daily volume shares moved at a decelerating pace. The close price INR decreased.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 07:57
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Medicap Q's gross margin accelerated to 44.72%, up from -81.97%.
The company's marginal operating leverage decelerated, while daily volume shares moved at a decelerating pace. The close price INR decreased.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 44.72 % | -81.97 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -81.97 % | -14.17 | ▼ |
| REVENUE_GROWTH_YOY | 3.7 % | — | - |
| PRICE_CHANGE_PERCENT | -1.116 % | — | - |
| DAILY_VOLUME | 50 shares | 3,719 | ▼ |
| CLOSE_PRICE | 25.7 INR | 25.99 | ▼ |
Cite this
Source: Samhati evidence synthesis for MEDICAPQ (2026-10-21). Observation: Medicap Q's gross margin accelerated to 44.72%, up from -81.97%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/medicapq
Filing step-changes